Thursday, December 5, 2019

Selected NIAID Science News Highlights of 2019

NIAID Logo

 

Thursday, December 5, 2019

Selected NIAID Science News Highlights of 2019

Collage showing Ebola treatment center, diagram of gene therapy, image of enterovirus, and clinical trial participant receiving a vaccine

As 2020 approaches, a new slideshow highlights selected NIAID science news from 2019. This year saw advances in treating Ebola, developing gene therapy for a rare immunologic disorder, and understanding the causes of acute flaccid myelitis.

Other work accelerated progress toward development of a universal flu vaccine, enhanced knowledge of organ transplantation among people with HIV, and provided new tools for studying human prion diseases. In addition, NIAID made strides toward ending the HIV epidemic in the United States and preventing tuberculosis, the leading infectious cause of death worldwide.

View the slideshow


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107 GovDelivery logo

No comments:

Post a Comment